Banco Latinoamericano de Exportaciones S.A. Sep 04

  • ID: 2092304
  • September 2004
  • Standard & Poors
1 of 3

Preferred creditor status in most countries in the region Good liquidity levels Focus on less vulnerable trade finance operations, with deep knowledge in the market in which it operates Decreased operating revenues during the past three years Vulnerability to economic cycles in the region Still-high concentration of operations in risky markets Banco Latinoamericano de Exportaciones S.A.'s (Bladex) investment-grade ratings emphasize its institutional role in the Latin American region as a premier source of trade finance; its strong knowledge and relationships in its core market; the benefits derived from its shareholder base, particularly regional Central Banks; its ability to confront regional crises; and good liquidity management. The ratings are balanced by the sharp reduction of its balance sheet during the past...

Companies mentioned in this report are:
- Banco Latinoamericano de Comercio Exterior S.A.

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- Banco Latinoamericano de Comercio Exterior S.A.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.